Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden · Delayed Price · Currency is SEK 238.00
-6.00 (-2.46%)
Sep 24, 2026, 5:29 PM CET
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 7.5 billion as of September 24, 2026. Its market cap has increased by 35.30% in one year.
Market Cap
7.50B
Enterprise Value
7.31B
Revenue
895.23M
Ranking
n/a
PE Ratio
84.64
Stock Price
238.00
ChartMarket Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 371.69M to 7.50B, an increase of 1,916.96%. That is a compound annual growth rate of 23.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 7.50B | 27.55% |
| Dec 30, 2025 | 5.88B | -61.84% |
| Dec 30, 2024 | 15.40B | 48.41% |
| Dec 29, 2023 | 10.38B | 90.12% |
| Dec 30, 2022 | 5.46B | -33.55% |
| Dec 30, 2021 | 8.22B | -8.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 53.68B |
| Elekta AB | 20.65B |
| Nolato AB | 14.63B |
| Vitrolife AB | 12.83B |
| MedCap AB | 8.09B |
| CellaVision AB | 4.01B |
| BICO Group AB | 1.59B |
| Paxman AB | 1.39B |